@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@cnet.com 3 years ago
Samsung invests in genetics-focused telehealth company as coronavirus rages - CNET
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@tech.eu 3 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@techcrunch.com 4 years ago
Verily, Alphabet’s other money-making, non-Google business, partners with Color on genetic analysis
@extremetech.com 5 years ago
23andMe, GlaxoSmithKline Will Use Your DNA to Develop New Drugs
@venturebeat.com 5 years ago
Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer’s Risk to Include Saliva Samples
@venturebeat.com 6 years ago
Cytox Awarded New Innovate UK Funding for Alzheimer’s Testing
@theverge.com 7 years ago
No doctor required: 23andMe cleared by FDA for at-home DNA tests
@WIRED 7 years ago
Genetic testing company Counsyl built their own robots to do the work most scientists hate doing.
@theverge.com 8 years ago
Ancestry.com is talking to the FDA about using DNA to estimate people's risk of disease
@venturebeat.com 8 years ago
Precision medicine ideas for VCs and angel investors
@theverge.com 8 years ago
Google's Calico partners with Ancestry.com to beat the specter of aging
@theverge.com 9 years ago
23andMe to offer users' medical data to Pfizer for research
@gigaom.com 9 years ago
IBM Watson invests in personal health company